Christopher Thomas Scott
Affiliation: Stanford University
- The case for stem cell counselorsChristopher Thomas Scott
Stanford University Program on Stem Cells in Society, Stanford, CA 94305, USA Electronic address
Stem Cell Reports 4:1-6. 2015..Finally, a candidate recruitment and clinical site interface scheme is offered. ..
- Wrongful termination: lessons from the geron clinical trialChristopher Thomas Scott
Center for Biomedical Ethics, Stanford University, Stanford, California, USA
Stem Cells Transl Med 3:1398-401. 2014..We offer recommendations for institutional review boards and clinical sites as they deliberate approvals of early-phase trials in frontier medicine. ..
- Democracy derived? New trajectories in pluripotent stem cell researchChristopher Thomas Scott
Stanford University Center for Biomedical Ethics Program on Stem Cells and Society, Stanford University, Stanford, CA 94305 5417, USA
Cell 145:820-6. 2011..Thus, we conclude that a ban on funding for embryonic stem cell research could have unexpected negative ramifications on the nascent field of hiPSCs...
- Overhauling clinical trialsChristopher Thomas Scott
Program on Stem Cells in Society, Stanford Center for Biomedical Ethics, Stanford, California, USA
Nat Biotechnol 25:287-92. 2007
- The road to pluripotence: the research response to the embryonic stem cell debateChristopher Thomas Scott
Center for Biomedical Ethics, Program on Stem Cells in Society, Department of Obstetrics and Gynecology, Stanford University School of Medicine, CA 94304, USA
Hum Mol Genet 17:R3-9. 2008..Human embryonic stem cell research is barely a decade old. The recent pace of discovery--in spite of federal restrictions--is testament to the potential of these cells to uncover some of biology's most intractable mysteries...
- Stem cells: new frontiers of ethics, law, and policyChristopher Thomas Scott
Program on Stem Cells in Society, Center for Biomedical Ethics, Stanford University, Palo Alto, California, USA
Neurosurg Focus 24:E24. 2008..The new landscape of ethics, law, and policy is discussed in the context of these developments, with an emphasis on the evaluation of risks and benefits for first-in-human clinical studies...
- The race is on: human embryonic stem cell research goes globalMindy C DeRouen
Program on Stem Cells in Society, Stanford University Center for Biomedical Ethics, Stanford, CA 94305, USA
Stem Cell Rev 8:1043-7. 2012..Over time, non-US labs have freely used lines on the US registries, while federally funded US scientists have been limited to using those lines approved by the NIH...
- Patenting pluripotence: the next battle for stem cell intellectual propertyKatja Triller Vrtovec
Center for Law and the Biosciences at Stanford University School of Law, Crown Quadrangle, 559 Nathan Abbott Way, Stanford, California 94305, USA
Nat Biotechnol 26:393-5. 2008..What will be the impact of induced pluripotent stem cell discoveries on the current stem cell patent landscape?..
- The paths around stem cell intellectual propertyKenneth S Taymor
Stanford University Program on Stem Cells in Society, Stanford University, 701 Welch Road, Palo Alto, California 94304, USA
Nat Biotechnol 24:411-3. 2006..Can new approaches for deriving human stem cells circumnavigate existing patents that dominate embryonic stem cell intellectual property?..
- Stem cell tourism and the power of hopeCharles E Murdoch
Center for Law and the Biosciences, Stanford University, USA
Am J Bioeth 10:16-23. 2010..We offer recommendations to clinicians and health care providers to help balance the discourse with individuals seeking treatment while guarding against fraud, misconception, and patient harm...
- Donation of embryos for human development and stem cell researchTasha Kalista
Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA 94305, USA
Cell Stem Cell 8:360-2. 2011..This consent methodology minimizes conflict of interest, respects patient choice, and provides a much-needed resource to patients and the research community...
- Mice with a human touchChristopher Thomas Scott
Nat Biotechnol 25:1075-7. 2007
- Chimeras in the crosshairsChristopher Thomas Scott
Nat Biotechnol 24:487-90. 2006
- The zinc finger nuclease monopolyChristopher Thomas Scott
Nat Biotechnol 23:915-8. 2005
- Chasing a cellular fountain of youthKen Howard Wilan
Nat Biotechnol 23:807-15. 2005